{"nct_id":"NCT00310895","title":"Safety and Dose Study of GRN163L Administered to Patients With Refractory or Relapsed Solid Tumor Malignancies","status":"COMPLETED","status_verified_date":"2015-12","start_date":"2006-03","start_date_type":null,"primary_completion_date":"2013-03","primary_completion_date_type":"ACTUAL","completion_date":"2013-03","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GERN"]}